삼성서울병원

Ko En
의료진 검색
찾으실 의료진명을 입력하여 검색해주세요.

방사선종양학과 김해영 교수

진료분야
유방암, 림프종, 특수방사선치료, 양성자치료
진료일정 09 月
날짜
일
01
월
02
화
03
수
04
목
05
금
06
토
07
일
08
월
09
화
10
수
11
목
12
금
13
토
14
일
15
월
16
화
17
수
18
목
19
금
20
토
21
일
22
월
23
화
24
수
25
목
26
금
27
토
28
일
29
월
30
오전
오후
진료일정 10 月
날짜
화
01
수
02
목
03
금
04
토
05
일
06
월
07
화
08
수
09
목
10
금
11
토
12
일
13
월
14
화
15
수
16
목
17
금
18
토
19
일
20
월
21
화
22
수
23
목
24
금
25
토
26
일
27
월
28
화
29
수
30
목
31
오전
오후
본원외래 본원클리닉 본원육아상담 암병원외래 암병원클리닉 암병원육아상담

학력

학력
2015.02 성균관대학교 의학과 박사 졸업
2008.02 성균관대학교 의학과 석사 졸업
2004.02 성균관대학교 의학과 졸업

경력

경력
2023.04 ~현재 삼성서울병원 방사선종양학과 의국장
2020.03 ~현재 삼성서울병원 방사선종양학과 부교수
2019.03 ~ 2020.02 삼성서울병원 방사선종양학과 전임대우 조교수
2018.03 ~ 2019.02 삼성서울병원 방사선종양학과 진료조교수
2011.03 ~ 2018.02 한림대학교병원 방사선종양학과 임상조교수 및 조교수
2009.03 ~ 2010.02 서울대학교병원 방사선종양학과 임상강사
2005.03 ~ 2009.02 삼성서울병원 레지던트
2004.03 ~ 2005.02 삼성서울병원 인턴

학회활동

학회활동
2023.11 ~ 현재 대한방사선종양학회 재무이사
2021.07 ~ 현재 Journal of Breast Cancer Associate Editor
2020.12 ~ 현재 대한림프부종학회 무임소이사
2016.01 ~ 현재 대한부인종양연구회 정회원
2013.01 ~ 현재 한국유방암학회 정회원
2009.04 ~ 현재 대한종양내과학회 정회원
2009.03 ~ 현재 대한방사선종양학회 정회원
2021.11 ~ 2023.10 대한방사선종양학회 용어위원회
2022.07 ~ 2023.04 GBCC2023 Vice chair of the Scientific Committee
2021.07 ~ 2023.04 한국유방암학회 국제위원회 위원
2020.02 ~ 2021.08 대한방사선종양학회 유방암분과 간사
2020.07 ~ 2021.04 GBCC10 Member of Scientific Program Committee
2019.05 ~ 2021.04 한국유방암학회 진료권고안위원회 간사 - 제1소위원회(비침습유방암)
논문
  • MED DOSIM 2024 10.1016/j.meddos.2023.08.007 Dosimetric comparison between RapidArc and HyperArc in hippocampal-sparing whole-brain radiotherapy with a simultaneous integrated boost Kim, J; Kim, TG; Park, B; Kim, H; Song, YG; Lee, HW; Kim, YZ; Ji, JH; Kim, SH; Kim, SM; Lee, JH; Kim, H
    View PubMed
  • BREAST CANCER-TOKYO 2024 10.1007/s12282-024-01547-9 Outcomes of whole breast radiation therapy in Asian breast cancer patients with prior cosmetic implants Kim, N; Cho, WK; Park, W; Lee, JE; Nam, SJ; Kim, SW; Yu, JH; Chae, BJ; Lee, SK; Ryu, JM; Ko, ES; Kim, H
    View PubMed
  • CANCER RES TREAT 2024 10.4143/crt.2023.996 Implication of Pre- and Post-radiotherapy ctDNA Dynamics in Patients with Residual Triple-Negative Breast Cancer at Surgery after Neoadjuvant Chemotherapy: Findings from a Prospective Observational Study Lee, TH; Kim, H; Kim, YJ; Park, WY; Park, W; Cho, WK; Kim, N
    View PubMed
  • SCI REP-UK 2024 10.1038/s41598-023-50840-8 Tailored radiation dose according to margin width for patients with ductal carcinoma in situ after breast-conserving surgery Kim, H; Kim, TG; Park, B; Kim, J; Jun, SY; Lee, JH; Choi, HJ; Jung, CS; Lee, HW; Lee, JS; Nam, HY; Shin, S; Kim, SM; Kim, H
    View PubMed
  • J KOREAN PHYS SOC 2024 10.1007/s40042-023-00998-1 Search for practical scaling factors of Bragg peak arrangement for line-scanning proton beam therapy in RayStation Chung, K; Kim, N; Cho, WK; Kim, H; Oh, D; Park, W; Park, HC; Lim, D
    View PubMed
  • BREAST 2023 10.1016/j.breast.2023.103594 Benefit of postoperative regional nodal irradiation in patients receiving preoperative systemic therapy with docetaxel/carboplatin/trastuzumab/ pertuzumab for HER2-positive breast cancer Kim, N; Kim, JY; Park, W; Cho, WK; Kim, TG; Im, YH; Ahn, JS; Lee, JE; Nam, SJ; Kim, SW; Yu, J; Chae, BJ; Lee, SK; Ryu, JM; Park, YH; Kim, H
    View PubMed
  • CANCERS 2023 10.3390/cancers15225473 The Role of Post-Mastectomy Radiotherapy in T1-2N1 Breast Cancer Patients: Propensity Score Matched Analysis Kim, K; Park, W; Kim, H; Cho, WK; Kim, N; Nam, SJ; Kim, SW; Lee, JE; Yu, J; Chae, BJ; Lee, SK; Ryu, JM
    View PubMed
  • RADIAT ONCOL 2023 10.1186/s13014-023-02357-7 Impact of high dose radiotherapy for breast tumor in locoregionally uncontrolled stage IV breast cancer: a need for a risk-stratified approach Kim, N; Kim, H; Park, W; Cho, WK; Kim, TG; Im, YH; Ahn, JS; Park, YH; Kim, JY
    View PubMed
  • BREAST CANCER RES TR 2023 10.1007/s10549-023-07150-4 Olaparib enhances sensitization of BRCA-proficient breast cancer cells to x-rays and protons Park, S; Choi, C; Kim, H; Shin, YJ; Oh, Y; Park, W; Cho, WK; Kim, N
    View PubMed
  • BREAST CANCER RES TR 2023 10.1007/s10549-023-07146-0 Quantitative assessment of breast volume changes after whole-breast irradiation for breast cancer using breast auto-segmentation Lee, TH; Ahn, SH; Chung, K; Park, W; Cho, WK; Kim, N; Kim, TG; Kim, H
    View PubMed
  • BREAST 2023 10.1016/j.breast.2023.08.003 Effect of high-dose radiation therapy on positive margins after breast-conserving surgery for invasive breast cancer Kim, H; Kim, TG; Park, B; Kim, JH; Jun, SY; Lee, JH; Choi, HJ; Jung, CS; Bang, YJ; Lee, HW; Lee, JS; Nam, HY; Shin, S; Kim, SM; Kim, H
    View PubMed
  • CLIN TRANSL RAD ONCO 2023 10.1016/j.ctro.2023.100639 Long-term outcomes of intraoperatively-placed applicator brachytherapy for rapid completion of breast conserving treatment: An analysis of a prospective registry data Kim, H; Hieken, TJ; Abraha, F; Jakub, JW; Corbin, KS; Furutani, KM; Boughey, JC; Stish, BJ; Deufel, CL; Degnim, AC; Shumway, DA; Ahmed, SK; Piltin, MA; Sandhu, NP; Conners, AL; Ruddy, KJ; Mutter, RW; Park, SS
    View PubMed
  • CANCER RES TREAT 2023 10.4143/crt.2022.410 Epidemiology of Second Non-breast Primary Cancers among Survivors of Breast Cancer: A Korean Population-Based Study by the SMARTSHIP Group Kim, H; Kim, SS; Lee, JS; Yoon, JS; Youn, HJ; Shin, H; Lee, JE; Lee, SK; Chung, IY; Jung, SY; Choi, YJ; Cho, J; Woo, SU
    View PubMed
  • EJSO-EUR J SURG ONC 2023 10.1016/j.ejso.2022.11.099 Omission of axillary lymph node dissection in patients with ypN plus breast cancer after neoadjuvant chemotherapy: A retrospective multicenter study (KROG 21-06) Park, Y; Shin, YS; Kim, K; Shin, KH; Chang, JH; Kim, SS; Jung, JH; Park, W; Kim, H; Kim, YB; Ahn, SJ; Kim, M; Kim, JH; Cha, HJ; Kim, TG; Park, HJ; Lee, SY
    View PubMed
  • BREAST 2022 10.1016/j.breast.2022.09.004 Suggestion for the omission of post-mastectomy chest wall radiation therapy in patients who underwent skin-sparing/ nipple-sparing mastectomy Kim, N; Park, W; Cho, WK; Kim, HY; Choi, DH; Nam, SJ; Kim, SW; Lee, JE; Yu, JH; Chae, BJ; Lee, SK; Ryu, JM; Mun, GH; Pyon, JK; Jeon, BJ
    View PubMed
  • RADIAT ONCOL 2022 10.1186/s13014-022-02140-0 Dummy run quality assurance study in the Korean Radiation Oncology Group 19-09 multi-institutional prospective cohort study of breast cancer Kim, M; Park, B; Kim, H; Kim, YJ; Choi, DJ; Chung, W; Kim, YJ; Shin, HS; Im, JH; Suh, CO; Kim, JH; Ha, B; Kim, MY; Park, J; Lee, J; Ahn, SJ; Lee, SY; Kusumawidjaja, G; Lim, F; Cho, WK; Kim, H; Choi, DH; Park, W
    View PubMed
  • JPN J CLIN ONCOL 2022 10.1093/jjco/hyac161 Patterns of regional recurrence according to molecular subtype in patients with pN2 breast cancer treated with limited field regional irradiation Cho, WK; Park, W; Jeong, Y; Kim, H; Kim, N
    View PubMed
  • CANCER RES TREAT 2022 10.4143/crt2021.933 Postmastectomy Radiation Therapy for Node-Negative Breast Cancer of 5 cm or Larger Tumors: A Multicenter Retrospective Analysis (KROG 20-03) Kim, K; Jung, J; Kim, H; Jung, W; Shin, KH; Chang, JH; Kim, SS; Park, W; Chang, JS; Kim, YB; Ahn, SJ; Lee, IJ; Lee, JH; Park, HJ; Cha, J; Kim, J; Choi, JH; Koo, T; Kwon, J; Kim, JH; Kim, MY; Park, SH; Kim, YJ
    View PubMed
  • CLIN BREAST CANCER 2022 10.1016/j.clbc.2021.06.013 Quantitative Changes in Skin Composition Parameters after Radiation Therapy According to Surgery Types Among Patients with Breast Cancer: A Prospective Study Yoo, GS; Kang, D; Kim, IR; Park, H; Kim, E; Cho, WK; Kim, H; Choi, DH; Ma, JC; Park, W
    View PubMed
  • BREAST CANCER RES TR 2022 10.1007/s10549-021-06507-x Validation of a nomogram for predicting the risk of lymphedema following contemporary treatment for breast cancer: a large multi-institutional study (KROG 20-05) Byun, HK; Kim, JS; Chang, JS; Cho, Y; Ahn, SJ; Yoon, JH; Kim, H; Kim, N; Choi, E; Park, H; Kim, K; Park, SH; Rim, CH; Choi, HS; Oh, YK; Lee, IJ; Shin, KH; Kim, YB
    View PubMed
  • RADIAT ONCOL 2022 10.1186/s13014-022-01998-4 Patient-related risk factors for late rectal bleeding after hypofractionated radiotherapy for localized prostate cancer: a single-center retrospective study Kim, TG; Park, B; Song, YG; Lee, HW; Oh, TH; Ryu, DS; Jeong, SC; Cho, D; Oh, J; Kim, KM; Lee, JW; Lee, HS; Kong, SM; Kim, JY; Kim, H
    View PubMed
  • BREAST CANCER RES TR 2022 10.1007/s10549-021-06483-2 Immediate breast reconstruction has no impact on the oncologic outcomes of patients treated with post-mastectomy radiation therapy: a comparative analysis based on propensity score matching Kim, N; Kim, H; Park, W; Choi, DH; Cho, WK; Nam, SJ; Lee, JE; Kim, SW; Yu, J; Lee, SK; Jeon, BJ; Pyon, JK; Mun, GH; Kim, TG
    View PubMed
  • BREAST 2021 10.1016/j.breast.2021.11.005 Novel prognostic classification predicts overall survival of patients receiving salvage whole-brain radiotherapy for recurrent brain metastasis from breast cancer: A recursive partitioning analysis (KROG 16-12) Kim, JS; Kim, K; Jung, W; Shin, KH; Im, SA; Kim, YB; Chang, JS; Choi, DH; Kim, H; Park, YH; Kim, DY; Kim, TH; Kwon, J; Kang, KM; Chung, WK; Kim, KS; Kim, IA
    View PubMed
  • CANCERS 2021 10.3390/cancers13225835 Real-World Data from a Refractory Triple-Negative Breast Cancer Cohort Selected Using a Clinical Data Warehouse Approach Kim, H; Kim, HJ; Kim, H; Kim, HR; Jo, H; Hong, J; Kim, R; Kim, JY; Ahn, JS; Im, YH; Lee, SK; Kim, H; Shin, SY; Park, YH
    View PubMed
  • INT J RADIAT ONCOL 2021 10.1016/j.ijrobp.2021.07.005 What Is High-risk Breast Cancer With Pathologically Negative Lymph Nodes for Regional Recurrence? Kim, SW; Cho, WK; Choi, DH; Kim, H; Cho, O; Park, W; Chun, M
    View PubMed
  • BREAST CANCER RES TREAT 2021 10.1007/s10549-021-06296-3 Dynamics of circulating tumor DNA during postoperative radiotherapy in patients with residual triple-negative breast cancer following neoadjuvant chemotherapy: a prospective observational study Kim1, H; Kim, YJ; Park, D; Park, WY; Choi, DH; Park, W; Cho, WK; Kim, N
    View PubMed
  • J BONE ONCOL 2021 10.1016/j.jbo.2021.100368 Clinical and dosimetric risk factors for vertebral compression fracture after single-fraction stereotactic body radiation therapy for spine metastases Kim1, H; Pyo, H; Park, HC; Lim, DH; Yu, JI; Park, W; Ahn, YC; Choi, DH; Oh, D; Noh, JM; Cho, WK; Yoo, GS; Jung, SH; Kim, ES; Lee, SH; Park, SJ; Lee, CS
    View PubMed
  • ANTICANCER RES 2021 10.21873/anticanres.15100 Inter-institutional Variation in Intensity-modulated Radiotherapy for Breast Cancer in Korea (KROG 19-01) Kim1, K; Chun, M; Jin, H; Jung, W; Shin, KH; Shin, SS; Kim, YJ; Park, SH; Kim, JH; Kim, YH; Shin, HS; Kim, H; Kim, SS; Lee, JH; Kim, YB; Lee, SY; Choi, J; Oh, DH; Kang, KM; Kwon, J; Kim, MY; Koo, T; Park, HJ; Ahn, SJ
    View PubMed
  • RADIOTHER ONCOL 2021 10.1016/j.radonc.2021.02.033 Longitudinal impact of postmastectomy radiotherapy on arm lymphedema in patients with breast cancer: An analysis of serial changes in arm volume measured by infrared optoelectronic volumetry Kim1, N; Kim, H; Hwang, JH; Park, W; Cho, WK; Yeo, SM; Lee, H; Lee, SK
    View PubMed
  • SKIN PHARMACOL PHYS 2021 10.1159/000515962 Chronological Skin Changes Through Postmastectomy Radiotherapy Based on Radiotherapy Techniques: Using Quantitative Dermatological Measurements Yang1, K; Park, W; Cho, J; Kang, D; Choi, DH; Kim, H; Cho, WK; Park, H; Kim, E
    View PubMed
  • BREAST 2021 10.1016/j.breast.2021.01.003 Impact of radiation dose on complications among women with breast cancer who underwent breast reconstruction and post-mastectomy radiotherapy: A multi-institutional validation study Chung1, SY; Chang, JS; Shin, KH; Kim, JH; Park, W; Kim, H; Kim, K; Lee, IJ; Yoon, WS; Cha, J; Lee, KC; Kim, JH; Choi, JH; Ahn, SJ; Ha, B; Lee, SY; Lee, DS; Lee, J; Shin, SO; Lee, SW; Choi, J; Kim, MY; Kim, YJ; Im, JH; Suh, CO; Kim, YB
    View PubMed
  • J BREAST CANC 2021 10.4048/jbc.2021.24.e23 Impact of Breast Reconstruction on Biophysical Parameters of Mammary Skin in Patients Receiving Postmastectomy Radiotherapy for Breast Cancer Kim1, H; Kang, D; Park, W; Cho, J; Park, H; Kim, E; Choi, DH; Cho, WK; Jeon, BJ; Lee, KT
    View PubMed
  • BREAST 2021 10.1016/j.breast.2020.12.011 Outcome of radiotherapy for clinically overt metastasis to the internal mammary lymph node in patients receiving neoadjuvant chemotherapy and breast cancer surgery Kim1, H; Kim, SS; Lee, IJ; Shin, KH; Kim, K; Jung, JB; Kim, Y; Chang, JS; Choi, DH; Park, W; Yang, K; Chang, JH; Cha, J; Kim, JH; Lee, DS
    View PubMed
  • J BREAST CANC 2020 10.4048/jbc.2020.23.e66 Survival and Prognostic Factors for Breast Cancer Patients with Regional Oligo-Recurrence Baek1, JY; Choi, DH; Park, W; Kim, H; Cho, WK; Yoo, GS
    View PubMed
  • CANCERS 2020 10.3390/cancers12113261 Comparison of Dose Distribution in Regional Lymph Nodes in Whole-Breast Radiotherapy vs. Whole-Breast Plus Regional Lymph Node Irradiation An In Silico Planning Study in Participating Institutions of the Phase III Randomized Trial (KROG 1701) Kim1, H; Kim, H; Park, W; Baek, JY; Ahn, SJ; Kim, MY; Park, SH; Lee, IJ; Ha, I; Kim, JH; Kim, TH; Lee, KC; Lee, HS; Kim, TG; Kim, JH; Lee, JH; Jung, J; Cho, O; Chang, JS; Kim, ES; Jo, IY; Koo, T; Kim, K; Park, HJ; Shin, YJ; Ha, B; Kwon, J; Lee, JH; Moon, S
    View PubMed
  • ASIA-PAC J CLIN ONCO 2020 10.1111/ajco.13444 Distribution of tumor subtypes in bilateral breast cancer Comparison between synchronous and metachronous cancer Kim1, H; Lee, H; Choi, DH; Park, W; Cho, WK; Nam, SJ; Lee, JE; Kim, SW; Lee, SK; Cho, EY; Cho, SY
    View PubMed
  • LASER MED SCI 2020 10.1007/s10103-019-02930-1 Feasibility of photobiomodulation therapy for the prevention of radiodermatitis a single-institution pilot study Park1, JH; Byun, HJ; Lee, JH; Kim, H; Noh, JM; Kim, CR; Oh, D
    View PubMed
  • INT J MOL SCI 2020 10.3390/ijms21082691 Checkpoint Kinase 1 (CHK1) Inhibition Enhances the Sensitivity of Triple-Negative Breast Cancer Cells to Proton Irradiation via Rad51 Downregulation Choi1, C; Cho, WK; Park, S; Shin, SW; Park, W; Kim, H; Choi, DH
    View PubMed
  • RADIAT ONCOL 2020 10.1186/s13014-020-1464-0 Optimal radiotherapy for patients with internal mammary lymph node metastasis from breast cancer Yang1, K; Kim, H; Choi, DH; Park, W; Noh, JM; Cho, WK
    View PubMed
  • BREAST 2020 10.1016/j.breast.2019.10.017 Outcome of breast-conserving treatment for axillary lymph node metastasis from occult breast cancer with negative breast MRI Kim1, H; Park, W; Kim, SS; Ahn, SJ; Kim, YB; Kim, TH; Kim, JH; Choi, JH; Park, HJ; Chang, JS; Choi, DH
    View PubMed
  • BREAST 2019 10.1016/j.breast.2019.06.005 Is higher dose radiation necessary for positive resection margin after breast-conserving surgery for breast cancer? Cho1, WK; Choi, DH; Park, W; Kim, H; Cha, H
    View PubMed
  • J BREAST CANC 2019 10.4048/jbc.2019.22.e42 Gastric Complications after Adjuvant Radiotherapy for Breast Cancer Cho1, WK; Choi, DH; Park, W; Kim, H; Kim, S; Shin, MH; Cha, H
    View PubMed
  • INT J GYNECOL CANCER 2019 10.1136/ijgc-2019-000615 Para-aortic lymph node recurrence after curative radiotherapy for cervical cancer Cho1, WK; Kim, YI; Park, W; Yang, K; Kim, H; Cha, H
    View PubMed
  • BREAST 2019 10.1016/j.breast.2018.11.004 Adjuvant radiation therapy in small ductal carcinoma in situ Cho1, WK; Choi, DH; Kim, H; Noh, JM; Park, W; Cha, H
    View PubMed
  • Int J Gynecol Cancer. 2018, 28 (2):371-378 Tumor Boost Using External Beam Radiation in Cervical Cancer Patients Unable to Receive Intracavitary Brachytherapy: Outcome From a Multicenter Retrospective Study (Korean Radiation Oncology Group 1419). Haeyoung Kim1, Young Seok Kim, Ji Hyeon Joo, Keun-Yong Eom, Won Park, Jin Hee Kim, Jong Hoon Lee, Yeon Sil Kim, Seok Ho Lee, MD, Kijung Ahn, Yong Bae Kim, Me-Yeon Lee, and Sei Kyung Chang.
  • Cancer Res Treat. 2017, 49 (4):970-980 Prognostic Impact of Elective Supraclavicular Nodal Irradiation for Patients with N1 Breast Cancer after Lumpectomy and Anthracycline plus Taxane-based Chemotherapy (KROG 1418): A Multicenter Case-Controlled Study. Haeyoung Kim1, Won Park, Jeong Il Yu, Doo Ho Choi, Seung Jae Huh, Yeon-Joo Kim, Eun Sook Lee, Keun Seok Lee, Han-Sung Kang, In Hae Park, Kyung Hwan Shin, Kyubo Kim, Kyung Ran Park, Yong Bae Kim, Sung Ja Ahn, Jong Hoon Lee, Jin Hee Kim, Mison Chun, Hyung-Sik Lee, Jung Soo Kim and Jong Young Lee.
  • Oncotarget. Optimal radiation dose for patients with one to three lymph node positive breast cancer following breast-conserving surgery and anthracycline plus taxane-based chemotherapy: A retrospective multicenter analysis (KROG 1418). Haeyoung Kim1, Won Park, Jeong Il Yu, Doo Ho Choi, Seung Jae Huh, Yeon-Joo Kim, Eun Sook Lee, Keun Seok Lee, Han-Sung Kang, In Hae Park, Kyung Hwan Shin, Kyubo Kim, Kyung Ran Park, Yong Bae Kim, Sung Ja Ahn, Jong Hoon Lee, Jin Hee Kim, Mison Chun, Hyung-Sik Lee, Jung Soo Kim and Jong Young Lee.
  • Breast Cancer Res Treat. 2017; 161 (1): 95-102 Frequency of pathogenic germline mutation in CHEK2, PALB2, MRE11, and RAD50 in patients at high risk for hereditary breast cancer. Haeyoung Kim1, Dae-Yeon Cho, Doo Ho Choi, Mijin Oh, Inkyung Shin, Won Park, Seung Jae Huh, Seok Jin Nam, Jeong Eon Lee & Seok Won Kim.
  • J Gynecol Oncol. 2016;27 (3): e33? Current status of brachytherapy in Korea: a national survey of radiation oncologists Haeyoung Kim1, Joo-Young Kim, Juree Kim, Won Park, Young Seok Kim, Hak Jae Kim, Yong Bae Kim.
  • Cancer Res Treat. 2016; 48 (3): 955-961 Analysis of BRIP1 Variants among Korean Patients with BRCA1/2 Mutation-Negative High-Risk Breast Cancer. Haeyoung Kim1, Dae-Yeon Cho, Doo Ho Choi, Gee Hue Jung, Inkyung Shin, Won Park, Seung Jae Huh, Seok Jin Nam, Jeong Eon Lee, Won Ho Gil, Seok Won Kim.
  • Support Care Cancer. 2016; 24: 4399-4406 Evaluation of quality of life using a tablet PC-based survey in cancer patients treated with radiotherapy: a multi-institutional prospective randomized crossover comparison of paper and tablet PC-based questionnaires (KROG 12-01). Haeyoung Kim1, Hee Chul Park, Sang Min Yoon, Tae Hyun Kim, Jinsung Kim, Min Kyu Kang, Jinhong Jung, Sang-Won Kim, Ji Woon Yea, Sung Ho Park, Young Suk Park.
  • Familial Cancer. 2015; 14:365-371 Heterozygous Germline Mutation in NBS1 among Non-BRCA1/2 Korean Patients with High Risk Breast Cancer. Haeyoung Kim1, Dae-Yeon Cho, Doo Ho Choi, Gee Hue Jung , Inkyung Shin, Won Park, Seung Jae Huh , Sung-Won Kim, Sue K. Park, Jong Won Lee, Seok Jin Nam, Jeong Eon Lee, Won Ho Gil, Seok Won Kim.
  • The Breast. 2014; 06: 586-590 Excision alone for small size ductal carcinoma in situ of the breast. Haeyoung Kim1, Jae Myoung Noh, Doo Ho Choi, Jihye Lee, Seok Jin Nam, Jeong Eon Lee, Won Park, Seung Jae Huh.
  • Cancer Res Treat. 2014;46: 148-157 Impact on Loco-regional Control of Radiochemotherapeutic Sequence and Time to Initiation of Adjuvant Treatment in Stage II/III Rectal Cancer Patients Treated with Postoperative Concurrent Radiochemotherapy. Haeyoung Kim1, Eui Kyu Chie, Yong Chan Ahn, Kyubo Kim, Won Park, Won Sup Yoon, Seung Jae Huh, Sung W. Ha.
  • J Breast Cancer. 2014; 17: 69-75 Analysis of Predictive Factors for Lung Injury after Forward-Planned Intensity-Modulated Radiotherapy in Whole Breast Irradiation. Haeyoung Kim1, Hoonsik Bae, Me-Yeon Lee, Kwang-Ho Cheong, Kyoung Ju Kim, Taejin Han, Sei-Kwon Kang, Soah Park, Taejin Hwang, Jai-Woong Yoon, Lee Su Kim.

해당하는 결과가 없습니다.